Evidence map›Paper›PMID 39634619›Full record

ArticleNanophotonics (Berlin, Germany)2022

Multidimensional engineered metasurface for ultrafast terahertz switching at frequency-agile channels.

Yuze Hu, Mingyu Tong, Siyang Hu, Weibao He, Xiang'ai Cheng, Tian Jiang

Abstract read
In one paragraph

Article in Nanophotonics (Berlin, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuze HuCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, P. R. China.
Mingyu TongCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, P. R. China.
Siyang HuCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, P. R. China.
Weibao HeCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, P. R. China.
Xiang'ai ChengCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, P. R. China.
Tian JiangCollege of Advanced Interdisciplinary Studies, National University of Defense Technology, Changsha 410073, P. R. China.ORCID https://orcid.org/0000-0003-3343-5548

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability to actively manipulate free-space optical signals by using tunable metasurfaces is extremely appealing for many device applications. However, integrating photoactive semiconductors into terahertz metamaterials still suffers from a limited functionality. The ultrafast switching in picosecond timescale can only be operated at a single frequency channel. In the hybrid metasurface proposed here, we experimentally demonstrate a dual-optically tunable metaphotonic device for ultrafast terahertz switching at frequency-agile channels. Picosecond ultrafast photoswitching with a 100% modulation depth is realized at a controllable operational frequency of either 0.55 THz or 0.86 THz. The broadband frequency agility and ultrafast amplitude modulation are independently controlled by continuous wave light and femtosecond laser pulse, respectively. The frequency-selective, temporally tunable, and multidimensionally-driven features can empower active metamaterials in advanced multiplexing of information, dual-channel wireless communication, and several other related fields.

Indexed as

electromagnetically induced transparencyhybrid metasurfaceterahertz metamaterialsultrafast photoswitching

Identifiers

PMID39634619
PMCPMC11501612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.